ApolloBio Corp.
PrivateCompany Overview
ApolloBio Corp. is a biopharmaceutical company that focuses on the clinical development and commercialization of innovative oncology and infectious disease treatments in the Greater China region.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticaldrug licensingclinical developmentin-licensingoncologyinfectious diseaseregulatory approvalGreater China marketbiotechdrug commercializationgene therapyDNA immunotherapypharma bridgemarket entryclinical assets
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ApolloBio Corp. Comparables
Compare ApolloBio Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dongfang Lue | 92% | |
| Zai Lab Limited | 81% | |
| Hongkong Winhealth Pharma Group | 76% | |
ApolloBio Corp. Funding Rounds
Historical fundraising activity
ApolloBio Corp. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ApolloBio Corp.'s valuation, stock price, and market status.